The hypolipidemic effect may be mediated through downregulating targets related to cholesterol biosynthesis, such as SCAP, SREBP-2, and HMGCR, and upregulating LDLR, resulting in the alleviation of hyperlipidemia. Here, SREBF2 is linked to hyperlipidemia.